Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Cauli

Showing results (151-160 of 180) with videos related to

Pageof 18
Sort By:
The Journal of Rheumatology|February 18, 2011
Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT studyAlberto Cauli, Dafna D Gladman, Alessandro Mathieu, et al.
Rheumatology (Oxford, England)|May 25, 2026
Early belimumab accelerates renal response and reduces glucocorticoid exposure in lupus nephritis: a multicenter propensity-matched studyMariele Gatto, Claudio Cruciani, Marta Calatroni, et al.
International Journal of Rheumatic Diseases|March 4, 2024
Real-world effectiveness and persistence of golimumab as second-line anti-TNFα drug in rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis patients in Italy: GO-BEYOND, a 12-month prospective observational studySalvatore D'Angelo, Enrico Tirri, Angela Maria Giardino, et al.
Cell Reports|August 29, 2019
Molecular Portraits of Early Rheumatoid Arthritis Identify Clinical and Treatment Response PhenotypesMyles J Lewis, Michael R Barnes, Kevin Blighe, et al.
Frontiers in Medicine|December 15, 2023
Management of psoriatic arthritis: a consensus opinion by expert rheumatologistsSalvatore D'Angelo, Fabiola Atzeni, Maurizio Benucci, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 11, 2016
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic ArthritisLaura C Coates, Arthur Kavanaugh, Philip J Mease, et al.
Rheumatology (Oxford, England)|November 29, 2025
The impact of demographics on organ damage in Behçet's syndrome: a cross-sectional analysis of the international PROBE cohortAlberto Floris, Riccardo Laconi, Sarra Chadli, et al.
Rheumatology (Oxford, England)|June 14, 2023
Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registriesLouise Linde, Lykke M Ørnbjerg, Stylianos Georgiadis, et al.
Biologics : Targets & Therapy|November 5, 2025
Efficacy of Belimumab on Different Joint and Skin Manifestations of Systemic Lupus Erythematosus: Real-Life Data from a New Multicentric, Nationwide Italian Cohort (BeRLiSS-JS 2.0)Marisol Bracalenti, Margherita Zen, Benedetta Bianchi, et al.
Annals of the Rheumatic Diseases|November 28, 2025
Ultrasound for assessing disease activity and structural damage in psoriatic arthritis: the UPsA scores from a multicentre study by the Italian Society of RheumatologyAlen Zabotti, Matteo Piga, Marco Canzoni, et al.
Pageof 18

Showing results (151-160 of 180) with videos related to

Sort By:
Pageof 18
The Journal of Rheumatology|February 18, 2011
Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT studyAlberto Cauli, Dafna D Gladman, Alessandro Mathieu, et al.
Rheumatology (Oxford, England)|May 25, 2026
Early belimumab accelerates renal response and reduces glucocorticoid exposure in lupus nephritis: a multicenter propensity-matched studyMariele Gatto, Claudio Cruciani, Marta Calatroni, et al.
International Journal of Rheumatic Diseases|March 4, 2024
Real-world effectiveness and persistence of golimumab as second-line anti-TNFα drug in rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis patients in Italy: GO-BEYOND, a 12-month prospective observational studySalvatore D'Angelo, Enrico Tirri, Angela Maria Giardino, et al.
Cell Reports|August 29, 2019
Molecular Portraits of Early Rheumatoid Arthritis Identify Clinical and Treatment Response PhenotypesMyles J Lewis, Michael R Barnes, Kevin Blighe, et al.
Frontiers in Medicine|December 15, 2023
Management of psoriatic arthritis: a consensus opinion by expert rheumatologistsSalvatore D'Angelo, Fabiola Atzeni, Maurizio Benucci, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 11, 2016
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic ArthritisLaura C Coates, Arthur Kavanaugh, Philip J Mease, et al.
Rheumatology (Oxford, England)|November 29, 2025
The impact of demographics on organ damage in Behçet's syndrome: a cross-sectional analysis of the international PROBE cohortAlberto Floris, Riccardo Laconi, Sarra Chadli, et al.
Rheumatology (Oxford, England)|June 14, 2023
Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registriesLouise Linde, Lykke M Ørnbjerg, Stylianos Georgiadis, et al.
Biologics : Targets & Therapy|November 5, 2025
Efficacy of Belimumab on Different Joint and Skin Manifestations of Systemic Lupus Erythematosus: Real-Life Data from a New Multicentric, Nationwide Italian Cohort (BeRLiSS-JS 2.0)Marisol Bracalenti, Margherita Zen, Benedetta Bianchi, et al.
Annals of the Rheumatic Diseases|November 28, 2025
Ultrasound for assessing disease activity and structural damage in psoriatic arthritis: the UPsA scores from a multicentre study by the Italian Society of RheumatologyAlen Zabotti, Matteo Piga, Marco Canzoni, et al.
Pageof 18